EUVIMEDOpdag EUVIMED
Crossref

Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients

K H Dilcan, H T Gozdas

Acta Gastro Enterologica Belgica · 2024-10 · 87 (3) · 388-392

DOI: 10.51821/87.3.13290 ↗

At a glance

Journal article in Acta Gastro Enterologica Belgica, 2024-10. Written by K H Dilcan and 1 co-authors. Institution: Department of Infectious Diseases and Clinical Microbiology, Abant Izzet Baysal University Faculty of Medicine, Bolu, Turkey. Major MEDLINE topics: Hepatitis B, Chronic, Liver Cirrhosis, Biomarkers. Cited 4 times so far (Crossref); 18 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background & Aims: Chronic hepatitis B is still a major cause of morbidity and mortality worldwide. In recent years, there has been increasing research on inexpensive, noninvasive, reproducible methods for detecting fibrosis in the liver. In this study, we examined the efficacy of 15 different noninvasive fibrosis markers for predicting significant liver fibrosis in chronic hepatitis B patients.

Methods

Patients who underwent liver biopsy for chronic hepatitis B between 01.01.2010 and 01.01.2022 were retrospectively analysed. The study population was divided into two groups according to significant fibrosis (F≥3). Receiver operating characteristic analysis was performed to examine the diagnostic performance of these noninvasive fibrosis markers for the prediction of significant fibrosis. Multiple logistic regression analysis was used create a model which predicts significant fibrosis better than the individual markers.

Results

In total, 234 chronic hepatitis B patients were enrolled in this study. Among the 15 noninvasive fibrosis markers, King’s score was found to have the biggest AUC in predicting significant fibrosis (F≥3). Furthermore, a model containing King’s score, GUCI and GPR has the ability of prediction of significant fibrosis better than every individual marker (cut-off of the model >0,3356, p

Subjects

MeSH terms (MEDLINE)

Hepatitis B, ChronicLiver CirrhosisBiomarkersHumansFemaleMaleRetrospective StudiesAdultMiddle AgedBiopsyROC CurveLiver

Author keywords

GPRGUCIKing’s scorechronic hepatitis Bliver fibrosis

Substances

Biomarkers

Authors and institutions

  • Department of Infectious Diseases and Clinical Microbiology, Abant Izzet Baysal University Faculty of Medicine, Bolu, Turkey.

Cite

APA

Dilcan, K. H., & Gozdas, H. T. (2024). Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients. Acta Gastro Enterologica Belgica, 87(3), 388-392. https://doi.org/10.51821/87.3.13290

Vancouver

Dilcan KH, Gozdas HT. Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients. Acta Gastro Enterologica Belgica. 2024;87(3):388-392. doi:10.51821/87.3.13290

BibTeX
@article{Dilcan2024,
  author = {Dilcan, K H and Gozdas, H T},
  title = {Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2024},
  volume = {87},
  number = {3},
  pages = {388--392},
  doi = {10.51821/87.3.13290}
}
Start for free →